PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Cell and Gene Therapy

Upcoming Events

SLAS Europe – 7th April 2025
PEGS Boston – 17/02/2025
Biotechnology Show 2025: 20th January 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
news

3D printed scaffolds can regrow damaged nerves

Researchers from the University of Saskatchewan in Canada are looking at how we can use 3D printing to help damaged nervous systems to regrow Scientists have develo...
Continue Reading →
news

WHO SE Asia Region Parliamentarians make stronger commitments

The momentum picked up in recent years with WHO declaring ‘reducing preventable maternal, child and neonatal deaths’ as a flagship programme in South-East Asia Region...
Continue Reading →
news

Merck’s Keytruda gets approval in China for advanced melanoma

Melanoma is one of the fastest growing malignant cancers in China, increasing at an annual rate of 3-5 percent, which makes it one of the deadliest diseases in the co...
Continue Reading →
news

Daiichi acquires another ADC drug through Glycotope licensing deal

Daiichi Sankyo is bringing a seventh antibody-drug conjugate, or ADC, into its pipeline through a licensing agreement with German biotech Glycotope. Specific fin...
Continue Reading →
news

Wockhardt starts manufacturing and R&D facility in Dubai

With an aim to grow and further establish their international presence in pharmaceutical manufacturing, Wockhardt inaugurated a‘state-of-the-art’ manufacturing facili...
Continue Reading →
news

SanBio Receives $20 Million Grant From CIRM

CIRM is an agency of the State of California formed to accelerate the progress of regenerative medicine through a highly competitive grant program. Prospective grants...
Continue Reading →
news

Sales of Roche new drugs are surging. Will that be enough?

Quickening sales of Roche's newer medicines offset the impact of rising biosimilar competition during the second quarter, helping to drive a 7% year-over-year jump...
Continue Reading →
news

Gilead CEO Milligan out ahead of turnaround bid

In an unexpected statement ahead of its second quarter earnings release Wednesday evening, Gilead Sciences said its well-liked CEO John Milligan will step down and...
Continue Reading →
news

Positive Alzheimer’s results from Biogen, Eisai spark ‘cautious optimism’

Biogen and partner Eisai announced Wednesday that a once-failed experimental drug for Alzheimer's disease slowed cognitive decline in patients with early forms of ...
Continue Reading →
news

GSK signs $300M genetic testing deal

GSK and 23andMe will also work on earlier-stage programs. The partners plan to use 23andMe’s data to jointly discover drug targets. GlaxoSmithKline has made a $300 m...
Continue Reading →
Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Tosoh – 29.04.25
Eppendorf – 18.03.2025
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025